Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: The impact of the 2001 Bethesda System

Cancer

Volumn 108, Issue 1, 2006, Pages 39-44

  Bean, Sarah M ^a   Connolly, Kathy ^a   Roberson, Janie ^a   Eltoum, Isam ^a   Chhieng, David C ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

2001 Bethesda System; Cervicovaginal cytology; Endometrial carcinoma; Endometrial cells

Indexed keywords

2001 BETHESDA SYSTEM; ADULT; AGE; ARTICLE; CLINICAL ASSESSMENT; DISEASE CLASSIFICATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CYTOLOGY; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INCIDENCE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; ENDOMETRIUM; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33344462110     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21458     Document Type: Article

References (26)

1. Ashfaq R, Sharma S, Dulley T, Saboorian MH, Siddiqui MT, Warner C. Clinical relevance of benign endometrial cells in postmenopausal women. Diagn Cytopathol. 2001;25:235-238.
2. Brogi E, Tambouret R, Bell DA. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer. 2002;96:60-66.
3. Chang A, Sandweiss L, Bose S. Cytologically benign endometrial cells in the Papanicolaou smears of postmenopausal women. Gynecol Oncol. 2001;80:37-43.
4. Cherkis RC, Patten SF Jr., Andrews TJ, Dickinson JC, Patten FW. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol. 1988;71:242-244.
5. Cherkis RC, Patten SF Jr., Dickinson JC, Dekanich AS. Significance of atypical endometrial cells detected by cervical cytology. Obstet Gynecol. 1987;69:786-789.
6. Gomez-Fernandez CR, Ganjei-Azar P, Capote-Dishaw J, Averette HE, Nadji M. Reporting normal endometrial cells in Pap smears: an outcome appraisal. Gynecol Oncol. 1999;74:381-384.
7. Gondos B, King EB. Significance of endometrial cells in cervicovaginal smears. Ann Clin Lab Sci. 1977;7:486-490.
8. Kerpsack JT, Finan MA, Kline RC. Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma. South Med J. 1998;91:749-752.
9. Ng AB, Reagan JW, Hawliczek S, Wentz BW. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 1974;18:356-361.
10. Sarode VR, Rader AE, Rose PG, Rodriguez M, Abdul-Karim FW. Significance of cytologically normal endometrial cells in cervical smears from postmenopausal women. Acta Cytola 2001;45:153-156.
11. Yancey M, Magelssen D, Demaurez A, Lee RB. Classification of endometrial cells on cervical cytology. Obstet Gynecol. 1990;76:1000-1005.
12. Zucker PK, Kasdon EJ, Feldstein ML. The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer. 1985;56:2256-2263.
13. Gray JA, Nguyen GK. Cytologic detection of endometrial pathology by Pap smears. Diagn Cytopathol. 1999;20:181-182.
14. Kurman R, Solomon D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer, 1994.
15. Ng AB. The cellular detection of endometrial carcinoma and its precursors, Gynecol Oncol. 1974;2(2-3):162-179.
16. Papillo JL, St John TL. The effect of Bethesda 2001 on laboratory statistics [abstract]. Acta Cytol. 2002;46:923.
17. Chhieng DC, Roberson J, Gidley J, Eltoum I. Bethesda 2001. Impact on the reporting of gynecologic cytology. Acta Cytol. 2004;48:355-362.
18. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
19. Ng AB, Reagan JW, Cechner RL. The precursors of endometrial cancer: a study of their cellular manifestations. Acta Cytol. 1973;17:439-448.
20. Saad RS, Mahdavy M, Takei H, Ruiz B. Endometrial cells in cervical specimens of women > 40 years of age [abstract]. Acta Cytol. 2004;48:678.
21. Ely KA, Bregman S, Arnott CK. Clinical significance of reporting endometrial cells in patients over the age of 40 and its influence on the decision to biopsy [abstract]. Acta Cytol. 2004;48:678.
22. Papillo JL, Harmon ML, Mount SL, Copley-Woods N. Reporting of endometrial cells in women 40-50 results in increased endometrial biopsies with low yield [abstract]. Acta Cytol. 2004;48:677.
23. Mount SL, Wegner EK, Eltabbakh GH, Olmstead JI, Drejet AE. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy. Obstet Gynecol. 2002;100:445-450.
24. Long DK, Biscotti C. An analysis of the Bethesda System 2001 guideline for reporting benign endometrial cells [abstract]. Acta Cytol. 2004;48:676.
25. Simsir A, Carter W, Elgert P, Cangiarella J. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Am J Clin Pathol. 2005;123:571-575.
26. Wu HH, Schuetz MJ 3rd, Cramer H. Significance of benign endometrial cells in Pap smears from postmenopausal women. J. Reprod Med. 2001;46:795-798.